Zio ECG Utilization Software (ZEUS) System vs LINQ II Insertable Cardiac Monitor
AI Verdict
Choose Zio ECG Utilization Software (ZEUS) System if…
Choose Zio ECG Utilization Software (ZEUS) if you require a non-invasive, short-to-medium term (up to 14 days) continuous ECG monitoring solution for initial arrhythmia diagnosis and management. This cloud-based system is ideal for rapid analysis and comprehensive reporting, leveraging AI to quickly identify and classify cardiac events from wearable Zio monitors.
View Zio ECG Utilization Software (ZEUS) System →Choose LINQ II Insertable Cardiac Monitor if…
Choose Medtronic LINQ II Insertable Cardiac Monitor if your patient requires long-term, discreet cardiac rhythm monitoring for up to 4.5 years, especially when arrhythmias are suspected to be infrequent or paroxysmal. This insertable device offers superior patient convenience, remote programming capabilities, and is suitable for pediatric patients (ages 2+) and those needing MRI compatibility.
View LINQ II Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio ECG Utilization Software (ZEUS) System | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Deployment | Cloud-based. | Subcutaneous implant with remote monitoring via mobile app or home communicator. |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
LINQ II Insertable Cardiac MonitorTool B (LINQ II) offers remote programming capabilities for its insertable device, which significantly reduces the need for patient office visits for device adjustments, streamlining clinician workflow. Additionally, its AccuRhythm AI algorithms reduce false alerts, saving clinicians considerable review time and improving overall efficiency.
Clinical Value
LINQ II Insertable Cardiac MonitorTool B (LINQ II) provides superior long-term monitoring capabilities, offering up to 4.5 years of continuous heart rhythm monitoring from an insertable device, which is crucial for detecting infrequent arrhythmias. Its AccuRhythm AI algorithms also significantly reduce false alerts (up to 88.2% for AF and 97.4% for Pause), leading to more accurate and actionable clinical data.
Pricing & Value
Zio ECG Utilization Software (ZEUS) SystemBoth tools have undisclosed pricing, making a direct comparison difficult. However, Tool A (ZEUS) has published studies demonstrating its cost-effectiveness, showing an incremental cost-effectiveness ratio of $17,000 per quality-adjusted life year gained and indicating savings by enabling early diagnosis and reducing emergency department visits.
Enterprise Readiness
Zio ECG Utilization Software (ZEUS) SystemWhile both are FDA cleared and HIPAA compliant, Tool A (ZEUS) demonstrates strong enterprise readiness through its announced collaboration with Epic to integrate Zio services into EHR platforms via Epic's Aura. This integration aims to significantly streamline workflows and reduce integration time for health systems, benefiting a large portion of the U.S. healthcare market.
Innovation
LINQ II Insertable Cardiac MonitorTool B (LINQ II) stands out with its innovative combination of an insertable cardiac monitor offering up to 4.5 years of continuous monitoring and the industry-first remote programming capability. Its AccuRhythm AI algorithms also represent a significant advancement in reducing false alerts, thereby enhancing diagnostic efficiency and clinician workflow.
Support & Docs
Zio ECG Utilization Software (ZEUS) SystemTool A (ZEUS) explicitly details dedicated support for products, billing, and reimbursement, including patient financial navigators and a specialized billing team. This comprehensive approach to administrative and financial support, alongside available instructions for use and clinical manuals, provides a more transparent and robust support structure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio ECG Utilization Software (ZEUS) System | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Product Name | Zio ECG Utilization Software (ZEUS) System | LINQ II Insertable Cardiac Monitor |
| Company | iRhythm Technologies | Medtronic |
| Monitoring Duration | up to 14 days (continuous ECG data analysis) | Up to 4.5 years of continuous monitoring |
| AI Algorithm | AI algorithm for arrhythmia detection and classification, Proprietary deep-learned algorithms | AccuRhythmu2122 AI algorithms for enhanced accuracy, Innovative PVC detection algorithm |
| EHR Integration | HL7-based EHR integration | Not specified |
| Mobile Application | ZioSuite web portal and mobile application for healthcare professionals | MyCareLink Heartu2122 mobile app for data transmission |
Videos
Demos, reviews, and walkthroughs featuring Zio ECG Utilization Software (ZEUS) System and LINQ II Insertable Cardiac Monitor.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio ECG Utilization Software (ZEUS) System or LINQ II Insertable Cardiac Monitor
- LINQ II Insertable Cardiac Monitor vs Sleepiz One+
- LINQ II Insertable Cardiac Monitor vs EchoNext
- LINQ II Insertable Cardiac Monitor vs PMcardio
- LINQ II Insertable Cardiac Monitor vs Cardiomo
- Zio ECG Utilization Software (ZEUS) System vs EchoNext
- Zio ECG Utilization Software (ZEUS) System vs Sleepiz One+
Backers
Who funded each tool's parent company.